Pedro Rosa-Neto is interested in the structural changes that occur in the brain as a result of neurodegenerative disease.

Salah El Mestikawy studies neurons using glutamate as a neurotransmitter in healthy and diseased central nervous systems.  

Michel Perreault's main focus is the evaluation of psychiatric and substance abuse programs.  

Giamal Luheshi investigates how IL-1 is involved in the initiation and progression of the inflammatory events associated with some brain disorders.

Eric Latimer, PhD, is a health economist and looks for ways to improve the services to people with severe forms of mental illness.

Ridha Joober developed a pharmaco-genetic profile of schizophrenia that may lead to earlier diagnosis and more effective treatment.

Camillo Zacchia is Senior advisor, Mental Health Education Office (MHEO) at the Douglas Institute.

Jacques Tremblay is actively involved in quality assurance, and in improving the safety of medication use.

N.P. Vasavan Nair, M.D., FRCPC, has contributed to the Douglas Institute in a variety of capacities.

Jocelyne Lahoud is Administrative Director, Research Centre, Douglas Institute